Volitinib
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Food Effect
Conditions
Food Effect, Health Subjects
Trial Timeline
Nov 1, 2013 → Jun 1, 2014
NCT ID
NCT02017236About Volitinib
Volitinib is a phase 1 stage product being developed by HUTCHMED for Food Effect. The current trial status is completed. This product is registered under clinical trial identifier NCT02017236. Target conditions include Food Effect, Health Subjects.
What happened to similar drugs?
2 of 3 similar drugs in Food Effect were approved
Approved (2) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02017236 | Phase 1 | Completed |
| NCT01773018 | Phase 1 | Completed |
Competing Products
17 competing products in Food Effect